FFA
OPTN

Farther Finance Advisors’s OptiNose OPTN Stock Holding History

Farther Finance Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$9 – 4105
2024
Q3 		$5 Hold
1
– – ﹤0.01% 3966
2024
Q2 		$8 Sell
1
-3
-75% -$50 ﹤0.01% 3793
2024
Q1 		$84 Sell
4
-10
-71% -$222 ﹤0.01% 3407
2023
Q4 		$262 Buy
+14
New +$256 ﹤0.01% 3165

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Farther Finance Advisors's OPTN Position: Q4 2024 in Review

Farther Finance Advisors sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 1 share — an estimated $9 sold.

Farther Finance Advisors first reported a position in OPTN in Q4 2023 and held it in 4 quarters. The position peaked at $262 in Q4 2023. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • Farther Finance Advisors reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 1 OptiNose share in Q4 2024, an estimated $9.
  • Farther Finance Advisors first reported a position in OptiNose in Q4 2023 and held it in 4 quarters.
  • Farther Finance Advisors's OptiNose position peaked at $262 in Q4 2023.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on Farther Finance Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.